ConductScience.org, home
Validation of Predictors of OAC Initiation Using EMR Data
API referenceFor AI assistants

Trial · NCT03006341

Results by group68

Each measurement the trial posted, group by group, in the words and numbers it posted.

1 to 20 of 68

Download this page as JSON
OutcomeGroupCategoryValueSpreadUnits
Percentage of Patients With ObesityDabigatran EtexilateBefore PS matching58.2Percentage of patients
Percentage of Patients With ObesityWarfarinBefore PS matching51.7Percentage of patients
Percentage of Patients With ObesityDabigatran EtexilateAfter PS matching57.4Percentage of patients
Percentage of Patients With ObesityWarfarinAfter PS matching54.2Percentage of patients
Percentage of Patients SmokingDabigatran EtexilateBefore PS matching50.0Percentage of patients
Percentage of Patients SmokingWarfarinBefore PS matching51.8Percentage of patients
Percentage of Patients SmokingDabigatran EtexilateAfter PS matching50.0Percentage of patients
Percentage of Patients SmokingWarfarinAfter PS matching50.5Percentage of patients
Percentage of Patients With Alcohol ConsumptionDabigatran EtexilateBefore PS matching47.1Percentage of patients
Percentage of Patients With Alcohol ConsumptionWarfarinBefore PS matching50.9Percentage of patients
Percentage of Patients With Alcohol ConsumptionDabigatran EtexilateAfter PS matching50.0Percentage of patients
Percentage of Patients With Alcohol ConsumptionWarfarinAfter PS matching38.9Percentage of patients
Percentage of Patients With Abnormal Renal FunctionDabigatran EtexilateBefore PS matching5.5Percentage of patients
Percentage of Patients With Abnormal Renal FunctionWarfarinBefore PS matching11.7Percentage of patients
Percentage of Patients With Abnormal Renal FunctionDabigatran EtexilateAfter PS matching6.5Percentage of patients
Percentage of Patients With Abnormal Renal FunctionWarfarinAfter PS matching8.0Percentage of patients
Percentage of Patients With Bleeding History or PredispositionDabigatran EtexilateBefore PS matching3.4Percentage of patients
Percentage of Patients With Bleeding History or PredispositionWarfarinBefore PS matching4.7Percentage of patients
Percentage of Patients With Bleeding History or PredispositionDabigatran EtexilateAfter PS matching3.7Percentage of patients
Percentage of Patients With Bleeding History or PredispositionWarfarinAfter PS matching4.6Percentage of patients

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03006341/results

API referenceFor AI assistants